Skip to content
zameds

Turoctocog lfa (Novoeight)

Turoctocog lfa

Novo Nordisk (Pty) Ltd û (Rivonia)

Registration

Applicant
Novo Nordisk (Pty) Ltd û (Rivonia)
Registrations
6

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Novoeight 250 IU

EACH VIAL CONTAINS TUROCTOCOG LFA 250,0 IU

250 IU56045856/8.1/0458RegisteredNot determinedNone
Novoeight 500 IU

EACH VIAL CONTAINS TUROCTOCOG LFA 500,0 IU

500 IU56045956/8.1/0459RegisteredNot determinedNone
Novoeight 1 000 IU

EACH VIAL CONTAINS TUROCTOCOG LFA 1 000,0 IU

000 IU 156046056/8.1/0460RegisteredNot determinedNone
Novoeight 1 500 IU

EACH VIAL CONTAINS TUROCTOCOG LFA 1 500,0 IU

500 IU 156046156/8.1/0461RegisteredNot determinedNone
Novoeight 2 000 IU

EACH VIAL CONTAINS TUROCTOCOG LFA 2 000,0 IU

000 IU 256046256/8.1/0462RegisteredNot determinedNone
Novoeight 3 000 IU

EACH VIAL CONTAINS TUROCTOCOG LFA 3 000,0 IU

000 IU 356046356/8.1/0463RegisteredNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

No structure available

This product's active ingredient could not be matched to a single known compound.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles